From opioid maintenance to abstinence: a literature review

References

• Dole VP, Nyswander M. A medical treatment for diace- tylmorphine (heroin) addiction—a clinical trial with methadone hydrochloride. JAMA 1965;193:646.
   PubMed Web of Science ®Google Scholar
• Farrell M, Ward J, Mattick R et al. Fortnightly review— methadone-maintenance treatment in opiate dependence— a review. Br Med J 1994; 309: 997–1001.
   Google Scholar
• Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med 2000; 67: 347–64.
   Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2003;(2):CD002209.
   Google Scholar
• Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2003;(2):CD002207.
   Google Scholar
• Ward J, Mattick R, Hall W. Methadone maintenance treatment and other opioid replacement therapies. Amster- dam: Harwood Academic Publishers, 1998.
   Google Scholar
• Farre M, Mas A, Torrens M, Moreno V, Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend 2002; 65: 283–90.
   Google Scholar
• Ling W, Huber A, Rawson RA. New trends in opiate pharmacotherapy. Drug Alcohol Rev 2001; 20: 79–94.
   Google Scholar
• Kreek MJ. Methadone-related opioid agonist pharma- cotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 2000; 909: 186–216.
   Google Scholar
• Kreek MJ, Laforge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov 2002; 1: 710–726.
   Google Scholar
• Leshner AI, Koob GF. Drugs of abuse and the brain. Proc Assoc Am Physicians 1999; 111: 99–108.
   Google Scholar
• McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689–95.
   Google Scholar
• Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug Alcohol Depend 2000; 60: 275–86.
   Google Scholar
• Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol De- pend 2001; 62: 255–64.
   Google Scholar
• Robles E, Stitzer ML, Strain EC, Bigelow GE, Silverman K. Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug Alcohol Depend 2002; 65: 179–89.
   Google Scholar
• Sees KL, Delucchi KL, Masson C et al. Methadone maintenance vs 180-day psychosocially enriched detoxifica- tion for treatment of opioid dependence: a randomized controlled trial. JAMA 2000; 283: 1303–10.
   Google Scholar
• Bell J, Chan J, Kuk A. Investigating the influence of treatment philosophy on outcome of methadone mainte- nance. Addiction 1995; 90: 823–30.
   Google Scholar
• Caplehorn JRM. A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 1994; 29: 1361–75.
   Google Scholar
• Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend 1995; 40: 139–50.
   Google Scholar
• Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11: 261–78.
   Google Scholar
• Maddux JF, Desmond DP. Ten-year follow-up after admission to methadone maintenance. Am J Drug Alcohol Abuse 1992; 18: 289–303.
   Google Scholar
• Maddux JF, Desmond DP. Methadone-maintenance and recovery from opioid dependence. Am J Drug Alcohol Abuse 1992; 18: 63–74.
   Google Scholar
• Milby JB. Methadone maintenance to abstinence. How many make it? J Nerv Ment Dis 1988; 176: 409–22.
   Google Scholar
• Magura S, Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med 2001; 68: 62–74.
   Google Scholar
• Fudala PJ, Jaffe JH, Dax EM, Johnson RE. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther 1990; 147: 525–34.
   Google Scholar
• Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. Opioid antagonist challenges in bupre- norphine maintained patients. Drug Alcohol Depend 1990; 25: 73–8.
   Google Scholar
• Leonard BE. Fundamentals of psychopharmacology. Chi- chester: John Wiley, 1992.
   Google Scholar
• Lewis JW. Buprenorphine. Drug Alcohol Depend 1985;14: 363– 72.
   Google Scholar
• Berger H, Schwegler MJ. Voluntary detoxification of patients on methadone maintenance. Int J Addict 1973;8: 1043– 7.
   Google Scholar
• Cushman P Jr. Abstinence following detoxification and methadone maintenance treatment. Am J Med 1978;65: 46– 52.
   Google Scholar
• DeAngelis GG, Lehmann WX. Adolescents and short term, low dose methadone maintenance. Int J Addict 1973;8: 853– 63.
   Google Scholar
• Lowinson J, Berle B, Langrod J. Detoxification of long-term methadone patients: problems and prospects. Int J Addict 1976; 11: 1009–18.
   Google Scholar
• Riordan CE, Mezritz M, Slobetz F, Kleber HD. Successful detoxification from methadone maintenance. Follow-up study of 38 patients. JAMA 1976; 235: 2604–7.
   Google Scholar
• Senay EC, Dorus W, Goldberg F, Thornton W. Withdrawal from methadone maintenance. Rate of withdrawal and expectation. Arch Gen Psychiatry 1977; 34: 361–7.
   Google Scholar
• Stimmel B, Goldberg J, Cohen M, Rotkopf E. Detoxifica- tion from methadone maintenance: risk factors associated with relapse to narcotic use. Ann NY Acad Sci 1978; 311: 173–80.
   Google Scholar
• Ball JC, Ross A. The effectiveness of methadone main- tenance treatment: patients, programmes, services, and outcome. New York: Springer-Verlag, 1991.
   Google Scholar
• Judson BA, Ortiz S, Crouse L, Carney TM, Goldstein A. A follow-up study of heroin addicts five years after first admission to a methadone treatment programme. Drug Alcohol Depend 1980; 6: 295–313.
   Google Scholar
• Des J, Joseph H, Dole VP. Long-term outcomes after termination from methadone maintenance treatment. Ann NY Acad Sci 1981; 362: 231–8.
   Google Scholar
• McGlothlin WH, Anglin MD. Shutting off methadone. Costs and benefits. Arch Gen Psychiatry 1981; 38: 885–92.
   Google Scholar
• Breen C, Harris SJ, Lintzeris N et al. Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug Alcohol Depend 2003; 71: 49–55.
   Google Scholar
• Byrne A. Nine-year follow-up of 86 consecutive patients treated with methadone in general practice, Sydney, Australia. Drug Alcohol Rev 2000; 19: 153–8.
   Google Scholar
• Eklund C, Melin L, Hiltunen A, Borg S. Detoxification from methadone maintenance treatment in Sweden: long- term outcome and effects on quality of life and life situation. Int J Addict 1994; 29: 627–45.
   Google Scholar
• Eklund C, Hiltunen AJ, Melin L, Borg S. Factors associated with successful withdrawal from methadone maintenance treatment in Sweden. Int J Addict 1995; 30: 1335–53.
   Google Scholar
• Judson BA, Ortiz S, Crouse L, Carney TM, Goldstein A. A follow-up study of heroin addicts five years after first admission to a methadone treatment programme. Drug Alcohol Depend 1980; 6: 295–313.
   Google Scholar